HUP0401613A2 - (S)-2-Etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és egy szulfonil-karbamidot tartalmazó gyógyszer-kombináció - Google Patents

(S)-2-Etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és egy szulfonil-karbamidot tartalmazó gyógyszer-kombináció

Info

Publication number
HUP0401613A2
HUP0401613A2 HU0401613A HUP0401613A HUP0401613A2 HU P0401613 A2 HUP0401613 A2 HU P0401613A2 HU 0401613 A HU0401613 A HU 0401613A HU P0401613 A HUP0401613 A HU P0401613A HU P0401613 A2 HUP0401613 A2 HU P0401613A2
Authority
HU
Hungary
Prior art keywords
ethoxy
phenyl
propanoic acid
tert
sulonylurea
Prior art date
Application number
HU0401613A
Other languages
English (en)
Inventor
Peter Öhman
Original Assignee
Astrazeneca Ab,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, filed Critical Astrazeneca Ab,
Publication of HUP0401613A2 publication Critical patent/HUP0401613A2/hu
Publication of HUP0401613A3 publication Critical patent/HUP0401613A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A találmány tárgya gyógyszer-kombináció, ami (S)-2-etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagygyógyászatilag alkalmazható sóját, vagy a vegyület vagy a sószolvátját, vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat vagy gyógyászatilag alkalmazhatósóját vagy a vegyület vagy a só szolvátját tartalmazza, egy szulfonil-karbamiddal együtt. Ó
HU0401613A 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea HUP0401613A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101982A SE0101982D0 (sv) 2001-06-01 2001-06-01 Pharmaceutical combination
PCT/SE2002/001036 WO2002100413A1 (en) 2001-06-01 2002-05-30 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA

Publications (2)

Publication Number Publication Date
HUP0401613A2 true HUP0401613A2 (hu) 2004-11-29
HUP0401613A3 HUP0401613A3 (en) 2007-11-28

Family

ID=20284364

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401613A HUP0401613A3 (en) 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2)-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea

Country Status (21)

Country Link
US (1) US20040157927A1 (hu)
EP (1) EP1399166A1 (hu)
JP (1) JP2004532891A (hu)
KR (1) KR20040007624A (hu)
CN (1) CN1250226C (hu)
BR (1) BR0210127A (hu)
CA (1) CA2448763A1 (hu)
CO (1) CO5540382A2 (hu)
CZ (1) CZ20033235A3 (hu)
EE (1) EE200300583A (hu)
HU (1) HUP0401613A3 (hu)
IL (1) IL159035A0 (hu)
IS (1) IS7057A (hu)
MX (1) MXPA03011010A (hu)
NO (1) NO20035235D0 (hu)
PL (1) PL367890A1 (hu)
RU (1) RU2003136157A (hu)
SE (1) SE0101982D0 (hu)
SK (1) SK14722003A3 (hu)
WO (1) WO2002100413A1 (hu)
ZA (1) ZA200309263B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
NO20035235D0 (no) 2003-11-25
CO5540382A2 (es) 2005-07-29
CA2448763A1 (en) 2002-12-19
CZ20033235A3 (cs) 2004-12-15
SE0101982D0 (sv) 2001-06-01
EP1399166A1 (en) 2004-03-24
IS7057A (is) 2003-11-28
RU2003136157A (ru) 2005-05-20
ZA200309263B (en) 2005-03-11
CN1250226C (zh) 2006-04-12
SK14722003A3 (sk) 2004-08-03
BR0210127A (pt) 2004-06-08
US20040157927A1 (en) 2004-08-12
PL367890A1 (en) 2005-03-07
KR20040007624A (ko) 2004-01-24
JP2004532891A (ja) 2004-10-28
HUP0401613A3 (en) 2007-11-28
IL159035A0 (en) 2004-05-12
CN1537008A (zh) 2004-10-13
MXPA03011010A (es) 2004-02-27
EE200300583A (et) 2004-02-16
WO2002100413A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
NO2015002I2 (no) Ataluren (3-[5-(2-fluorfenyl)-[ 1,2,4]oksadiazol-3-yl]-benzosyre) og farmasøytisk akseptable salter og solvater derav
JP2004532209A5 (hu)
JP2009530231A5 (hu)
TR200003543T2 (tr) Yeni 3-aril-2-hidroksipropiyonik asit türevi III.
ATE518845T1 (de) Optische isomere eines iloperidon-metaboliten
RU2003136097A (ru) Производные фенилпиридинкарбонилпиперазина
AR049699A1 (es) Derivados de pirimidina
HRP20080446T3 (en) Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine
JP2009501704A5 (hu)
IS2473B (is) Samsetning sem inniheldur N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-(1,3,4-oxadíasól-2-ýl)fenýl)pýridín-3-súlfónamíð (ZD4054), eða lyfjafræðilega viðurkennt salt þess, og EGFR TKI, eða lyfjafræðilega viðurkennt salt þess
WO2007066163A3 (en) Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
DK1237855T3 (da) Krystallinsk form af (S)-2-ethoxy-3-[4-(2-(4-methansulfonyloxyphenyl)ethoxy)phenyl]propansyre
HUP0401613A2 (hu) (S)-2-Etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és egy szulfonil-karbamidot tartalmazó gyógyszer-kombináció
HUP0400964A2 (hu) (S)-2-Etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és inzulint tartalmazó gyógyszer-kombináció
HUP0400946A2 (hu) (S)-2-etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és egy gyógyhatású biguanidot tartalmazó gyógyszerkombináció
UA92770C2 (ru) СПОСОБ ПОЛУЧЕНИЯ {2-[4-(а-ФЕНИЛ-п-ХЛОРБЕНЗИЛ)-ПИПЕРАЗИН-1-ИЛ]-ЭТОКСИ}-УКСУСНОЙ КИСЛОТЫ N,N-ДИМЕТИЛАМИДА ИЛИ ЕГО ЭНАНТИОМЕРОВ
UY28371A1 (es) Agentes terapéuticos
CO5590908A2 (es) Derivados de acido 3-fenil-2-arilalquiltiopropionico como antagonistas selectivos de ppar-alfa
JP2005511785A5 (hu)
AU2034601A (en) Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid
JP2006241144A5 (hu)
HUP0303027A2 (hu) Új benzoil-guanidin só és alkalmazása gyógyszerkészítmény előállítására
TH26872B (th) สารประกอบต่าง ๆ ชนิดใหม่
JP2005516993A5 (hu)

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees